Bostwick Laboratories competitors

I am an aspiring sports broadcaster from Pembroke, Massachusetts. As a dedicated and hard-working leader, success is something I pride myself on. Thus, going above and beyond the bare minimum is something I strive for constantly. From the moment I stepped on campus at Quinnipiac University, I understood how extra curricular activities were the key to success. Therefore, I quickly joined student media organizations and gained extensive knowledge from the start. I now have two years experience in a student-run news room. Editing and shooting video, writing for print and for broadcast, play by play and color commentary, and control room operations are all skills I have gained from my hands on experience outside of the classroom.

Andrew Walton is a Chief Executive Officer at Miraca Life Sciences and Board Member at OXFORD IMMUNOTEC GLOBAL PLC. He has worked as Senior VP/CIO at LABORATORY CORP OF AMERICA HOLDINGS, Executive In Charge at LABORATORY CORP OF AMERICA HOLDINGS, and Exec VP:Strategic Planning at LABORATORY CORP OF AMERICA HOLDINGS. Andrew attended Yale University and Harvard Business School.

Alan Greenberg is a Chief Executive Officer and President at Sunrise Medical Laboratories and is based in Plainview, New York. He has worked as Chief Financial Officer at Sunrise Medical Laboratories and Sonic Healthcare USA-Northeast and Controller at QUEST DIAGNOSTICS INC.

Julie Faling is a Chief Executive Officer at HCFS and is based in Frisco, Texas. She studied at Oklahoma State University between 1982 and 1985.

Jake Orville has 20+ years of diagnostic, life science and medical device management experience within both established and emerging markets. As the General Manager of Pipeline at Exact Sciences, Jake leads the company's efforts to develop and advance solutions for earlier detection and life changing answers across the cancer continuum. Prior to Exact Sciences, Jake co-founded Cleveland HeartLab, Inc. (CHL) and served as the CEO from inception to exit. CHL was spun-out of the Cleveland Clinic to develop and rapidly commercialize unique diagnostic technologies, with applications in cardiovascular and inflammatory indications. CHL was acquired by Quest Diagnostics in December 2017. Jake Served as the General Manager of the Cardiometabolic & Endocrinology Franchise at Quest. Under Jake’s leadership, CHL was recognized as Ohio’s Venture of the Year (2012); received an Economic Impact Award by the city of Cleveland for job creation (2013) and was recognized as an Inc. 500 fastest growing private company in the US (2014). Jake has been recognized as a Top 50 Smart Leader by Smart Magazine and received the Annual Innovation Award in 2018 Prior to co-founding Cleveland HeartLab, Jake was CEO of Prognostix and held Senior Management positions with two publically traded companies (NextGen Sciences - AIM NGG.L; Third Wave Technologies - Nasdaq TWTI). He is a co-founder of Viridian Medical and Tolera Therapeutics and currently sits on the Board of Directors for The Wisconsin Women’s Health Foundation. Jake has raised capital from multiple sources, including top tier venture funds, strategic and international investors as well as angels, family offices and state funding sources. A well recognized entrepreneur, he has given many lectures on innovation, commercialization, early stage ventures, technology transfer and intellectual property. Jake received his Bachelor of Arts from the University of Massachusetts, Amherst and his MBA from the University of Wisconsin, Madison.